UroGen Pharma Ltd. (27)

Browse by Contract Category

Contracts

UroGen Pharma Ltd. 2017 Equity Incentive Plan, as amended (Filed With SEC on June 8, 2021)
Pre-Paid Forward Contract by and among the Registrant and RTW Investments ICAV for and on behalf of RTW Fund 2, dated as of March 18, 2021, as amended (Filed With SEC on May 13, 2021)
Amendment No. 1 to Sales Agreement, dated as of December 20, 2019, by and between the Registrant and Cowen and Company, LLC (Filed With SEC on November 9, 2020)
Lease Agreement, dated November 4, 2019, by and between the Registrant and Witman Properties, L.L.C. and Alexander Road at Davanne, L.L.C (Filed With SEC on March 2, 2020)
License Agreement, dated November 8, 2019, by and between the Registrant and Agenus Inc (Filed With SEC on March 2, 2020)
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the UroGen Pharma Ltd. 2019 Inducement Plan (Filed With SEC on May 28, 2019)
Amendment 2 to Employment Agreement between the Company and Mark Schoenberg, dated March 15, 2021 (Filed With SEC on May 13, 2021)
Amendment 1 to Employment Agreement between the Company and Jason Smith, dated January 26, 2021 (Filed With SEC on May 13, 2021)
Amendment 1 to Employment Agreement between the Company and Mark Schoenberg, dated January 26, 2021 (Filed With SEC on May 13, 2021)
Amendment 1 to Employment Agreement between the Company and Elizabeth Barrett, dated January 26, 2021 (Filed With SEC on May 13, 2021)
Omnibus Amendment to Equity Awards between the Company and Elizabeth Barrett, dated January 19, 2021 (Filed With SEC on May 13, 2021)
Employment Agreement between the Company and Jason Smith, dated August 12, 2020 (Filed With SEC on November 9, 2020)
Employment Agreement between the Company and Molly Henderson, dated September 3, 2020 (Filed With SEC on September 9, 2020)
Separation Agreement between the Company and Peter Pfreundschuh, dated September 8, 2020 (Filed With SEC on September 9, 2020)
UroGen Pharma Ltd. 2017 Equity Incentive Plan, as amended (Filed With SEC on June 10, 2020)
Separation Agreement between the Company and Stephen Mullennix, dated March 20, 2020 (Filed With SEC on March 23, 2020)
Description of the Registrants Ordinary Shares (Filed With SEC on March 2, 2020)
Form of Stock Option Grant Notice and Stock Option Agreement under the UroGen Pharma Ltd. 2019 Inducement Plan (Filed With SEC on May 28, 2019)
UroGen Pharma Ltd. 2019 Inducement Plan (Filed With SEC on May 28, 2019)
Employment Agreement by and between the Registrant and Elizabeth Barrett, dated as of January 3, 2019 (Filed With SEC on February 28, 2019)
Separation and Agreement between the Company and Gary Titus, dated as of July 11, 2018 (Filed With SEC on February 28, 2019)
Separation and Release Agreement between the Registrant and Ron Bentsur, dated as of January 3, 2019 (Filed With SEC on February 28, 2019)
Employment Agreement by and between the Registrant and Mark Schoenberg, dated as of December 5, 2017 (Filed With SEC on February 28, 2019)
Employment Agreement by and between the Registrant and Stephen Mullennix, dated as of January 17, 2018 (Filed With SEC on February 28, 2019)
Employment Agreement by and between the Registrant and Peter Pfreundschuh, dated as of July 31, 2018 (Filed With SEC on February 28, 2019)
2017 Equity Incentive Plan, as amended (Filed With SEC on February 28, 2019)
Underwriting Agreement, dated January 23, 2019 (Filed With SEC on January 25, 2019)